CD34 and CD38 Expression on Blasts in Myelodysplastic Syndromes and Secondary AML
The expression of a “stem cell like” blast immunophenotype (CD34+/CD38−) has been associated with a poor prognosis in AML. Advanced myelodysplastic syndromes and secondary AML’s are another patient population with an inferior prognosis. We hypothesized that a stem cell origin of these disorders results in a higher incidence of a CD34+/CD38− blast immunophenotype. This could be biologically related to a higher chemoresistence. The data presented here shows that a “stem cell like” blast immunophenotype is rare in RAEB. In addition there is no significant difference between primary AML and secondary AML or RAEB-T.
KeywordsAcute Myeloid Leukemia Myelodysplastic Syndrome Hematopoietic Progenitor Cell Leukemic Blast Inferior Prognosis
Unable to display preview. Download preview PDF.
- 1.Bennett JM, Catovsky D, Daniel M-T: Proposals for the classification of the myelodysplastic syndromes. Br.J. of Haematol 33: 329–331, 1982Google Scholar
- 3.Campos L, Guyotat D, Archimbaud E, Devaux Y Treille D, Larese A, Maupas J, Gentilhomme O.,Ehrsam A, Fiere D: Surface marker expression in adult acute myeloid leukemia: correlation with initial characteristics, morphology and response to therapy. Br. J. Haematol 72: 161–166, 1989PubMedCrossRefGoogle Scholar
- 5.Huang S, Terstappen LWMM: Lymphoid and myeloid differentiation of single human CD34+, HLA-DR-,CD38- hematopoietic stem cells. Blood 83: 1515–1526, 1993Google Scholar
- 9.Nylund S, Verbeek W, Larramendy ML, Ruutu T, Heinonen K, Hallman H, Knuutila S: Cell lineage involvement in four patients with myelodysplastic syndrome an t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybrisation. Cancer Genet Cytogenet 70: 120–124, 1993PubMedCrossRefGoogle Scholar
- 12.Wörmann B., D.Grove D., Unterhalt M.; Toepker S., Aul C. Heyll A. Büchner TH., Hiddemann W., Terstappen LW.M.M: Characterisation of CD 34+/CD38− acute myeloid leukemia. ASH Abstract, 1993Google Scholar